Medline ® Abstract for Reference 7
of 'Toxicities associated with checkpoint inhibitor immunotherapy'
7
TI
Anti-PD-1 therapy in patients with advanced melanoma and pre-existing autoimmune disorders or major toxicity with ipilimumab
AU
Menzies AM, Johnson DB, Ramanujam S, et al
SO
Ann Oncol. 2016;
AD